SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-008831
Filing Date
2024-01-31
Accepted
2024-01-31 16:30:48
Documents
1
Group Members
FAIRMOUNT HEALTHCARE CO-INVEST II LPFAIRMOUNT HEALTHCARE FUND II LPFAIRMOUNT HEALTHCARE FUND LPPETER HARWINTOMAS KISELAK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm244753d1_sc13da.htm SC 13D/A 120880
  Complete submission text file 0001104659-24-008831.txt   122856
Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

IRS No.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Subject) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94122 | Film No.: 24583374
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)